Amundi’s Hims & Hers Health HIMS Stock Holding History

Amundi’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$651K	Sell	18,791 -1,580	-8%	-$42.4K	﹤0.01%	1552
2026 Q1	$423K	Buy	20,371 +9,876	+94%	+$233K	﹤0.01%	1610
2025 Q4	$341K	Buy	+10,495	New	+$450K	﹤0.01%	1613
2025 Q3	–	Sell	-10,296	Closed	-$489K	–	1629
2025 Q2	$489K	Buy	10,296 +522	+5%	+$23.6K	﹤0.01%	1381
2025 Q1	$274K	Sell	9,774 -2,967	-23%	-$110K	﹤0.01%	1617
2024 Q4	$328K	Buy	12,741 +4,197	+49%	+$104K	﹤0.01%	1648
2024 Q3	$160K	Buy	8,544 +1,432	+20%	+$25.6K	﹤0.01%	1698
2024 Q2	$146K	Buy	7,112 +167	+2%	+$2.78K	﹤0.01%	1641
2024 Q1	$85.7K	Hold	6,945	–	–	﹤0.01%	1787
2023 Q4	$59.3K	Buy	6,945 +3,213	+86%	+$23.8K	﹤0.01%	1863
2023 Q3	$23.3K	Hold	3,732	–	–	﹤0.01%	1921
2023 Q2	$34K	Hold	3,732	–	–	﹤0.01%	1929
2023 Q1	$36.5K	Hold	3,732	–	–	﹤0.01%	1920
2022 Q4	$25.1K	Sell	3,732 -1,264	-25%	-$7.2K	﹤0.01%	1777
2022 Q3	$28K	Buy	+4,996	New	+$30.1K	﹤0.01%	1729

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Amundi's HIMS Position: Q2 2026 in Review

Amundi reduced its Hims & Hers Health (HIMS) stake by 7.8% in Q2 2026, selling an estimated $42.4K and leaving 18,791 shares worth $651K. The position accounts for ﹤0.01% of the portfolio, ranked #1552.

Amundi first reported a position in HIMS in Q3 2022 and has held it in 15 quarters since. 507 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Amundi held 18,791 shares of Hims & Hers Health worth $651K as of Q2 2026.
Amundi sold 1,580 Hims & Hers Health shares in Q2 2026, an estimated $42.4K.
Hims & Hers Health made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1552 holding.
Amundi first reported a position in Hims & Hers Health in Q3 2022 and has held it in 15 quarters since.
507 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.